The Colorectal Cancer Market is expected to grow from US$ 18,619.3 million in 2022 to US$ 24,078.5 million by 2028; it is expected to grow at a CAGR of 3.3% from 2022 to 2028.
The increasing prevalence of colorectal cancer and demand for advanced cancer diagnostics across the globe are driving the growth of the global colorectal cancer market. The government’s measures to control pharmaceutical prices are hampering the overall market growth. Rising market potential in developing economies is expected to provide lucrative opportunities for the global colorectal cancer market in the coming years. Furthermore, the growing number of product approvals and developments is likely to boost the market during the forecast period.
Colorectal cancer is also known as bowel, colon, or rectal cancer. This type of cancer is the second leading cause of death in women and the third leading cause of death in men. Colorectal cancer can be benign, noncancerous, or malignant. The symptoms of colon cancer patients include changes in bowel habits, diarrhea or constipation, and blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.
Get Sample PDF:
https://www.theinsightpartners.com/sample/TIPRE00006881/
Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. The diagnosis type segment accounted for the largest share of the market in 2022. Further, it is anticipated to register a higher CAGR during the forecast period, owing to an increasing number of diagnostics tests done by patients. The diagnosis type segment is further categorized into immunochemistry, stool test, flexible sigmoidoscopy, colonoscopy, CEA test, and others. Leading companies offer a huge range of products; for instance, Roche offers robust tools to aid in colorectal cancer diagnostics; the portfolio of assays includes VENTANA MLH-1 (M1) Mouse Monoclonal Primary Antibody, VENTANA anti-MSH6 (SP93) Rabbit Monoclonal Antibody, and VENTANA CDX-2 (EPR2764Y).
Buy Now: https://www.theinsightpartners.com/buy/TIPRE00006881/
Impact of COVID-19 Pandemic on Global Colorectal Cancer Market
The COVID-19 pandemic has significantly affected the global healthcare system. To combat the spread of SAR-CoV-2, governments imposed stringent policies in 2020 and 2021 to prevent and reduce infection and mortality rates. Due to lockdown and travel restrictions, the global colorectal cancer market was adversely affected. This is mainly due to reduced CRC screening to prevent cancer patients from frequent travel to hospitals. Furthermore, hospitals postponed or canceled lengthy procedures to free up limited space for COVID-19 patients. The cancellation of surgeries to reduce exposure to COVID-19 in the hospital hampered the growth of the colorectal cancer market. However, the world is slowly recovering from the COVID-19 pandemic and has resumed rebuilding lives and economies. Therefore, with the easing of lockdowns worldwide and the resumption of elective procedures, the colorectal cancer market is expected to recover the loss over the coming years significantly.
Company Profiles
· F. Hoffmann-La Roche AG
· Epigenomics AG
· Novigenix SA
· Abbott Laboratories
· Amgen Inc.
· Volitionrx
· EDP Biotech
· Clinical Genomics Technologies Pvt Ltd
· Bruker
· Quest Diagnostics Incorporated
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
The report "Polyurethane Market by Raw Material (MDI, TDI, Polyols), Product (Coatings, Adhesives & Sealants, Flexible & Rigid Foams, Elastomers), End User (Building & Construction, Automotive & Transportation, Bedding & Furniture) - Global Forecast to 2021", The market is driven by the increasing trend in manufacturing light weight & low carbon emitting vehicles and the improved living standards.
Get PDF brochure of the report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151784541 Browse 114 market data tables and 52 figures spread through 183 pages and in-depth TOC on “Polyurethane Market” Bedding & Furniture: Largest End-User of the Polyurethane MarketIn 2015, the bedding & furniture end-use industry accounted for the largest market share in terms of volume, followed by the building and construction, appliances & white goods and automotive & transportation end-users.
The growing urbanization and the improved living standards of the populations, increasing usage of low cost material in the insulation of buildings, and white goods drives the polyurethane market.
Rigid Foam: The Fastest-growing Product Type Segment of the Polyurethane MarketRigid foam products based on polyurethane systems are estimated to grow at the highest CAGR from 2016 to 2021, in terms of volume.
The excellent properties of rigid foam products such as, easy availability, low cost, recyclability, and easy to use, are driving the demand for this segment.
However, India and Thailand are the fastest-growing markets for polyurethane in the region.The following factors are the main driving forces for the polyurethane market in the Asia-Pacific region:The increasing residential building & construction activities are driving the market in the Asia-Pacific region Growing automotive manufacturing activities are expected to drive the demand for polyurethane in the ASEAN countries Covestro AG (Germany), BASF SE (Germany), The Dow Chemical Company (U.S.), Wanhua Chemical Group Co. Ltd. (China), and Huntsman Corporation (U.S.) are the key players in the polyurethane market.
The Colorectal Cancer Therapeutic Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the colorectal cancer therapeutic market include HOFFMANN LA ROCHE, DEBIOPHARM GROUP, MERCK KGAA, VACCINOGEN BD, Aeterna Zentaris, Keryx 326, Spectrum Pharmaceuticals, Inc., MOLOGEN AG Company, AMGEN, Bayer HealthCare and others.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Colorectal Cancer Therapeutic Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/colorectal-cancer-therapeutic-market/download-sampleMarket DynamicsSurging prevalence of fatal diseases such as cancer across the world and abrupt advancements in new techniques for the therapy of cancer such as colorectal cancer is anticipated to be the prominent factor behind the growth of global colorectal cancer therapeutics market during the forecast years.
Along with the rise in cancer prevalence, the increase in partnership between different pharmaceutical groups, and the surge in cancer research are the fundamental aspects that strengthen the growth of the market.
Similarly, expansion of the geriatric population is predicted to stimulate market growth in the coming years.
